Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3033463	li-neutrof	— (—)	43	47	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Other symptoms and signs involving the nervous and musculoskeletal systems

19.10

14.19

1.1

1.0

—

Symptoms and signs involving the nervous and musculoskeletal systems

14.00

12.71

1.1

1.0

—

Fever of other and unknown origin

17.32

10.25

1.1

1.0

—

Headache

13.13

9.56

1.1

—

General symptoms and signs

9.52

8.24

1.1

—

Fitting and adjustment of other devices

17.62

7.89

1.1

1.0

—

Special screening examination for other diseases and disorders

+∞

7.29

1.1

0.0

—

Neurological diseases

10.87

6.14

1.1

1.0

—

General examination and investigation of persons without complaint and reported diagnosis

12.46

6.06

1.1

1.0

—

Mouth breathing

8.56

6.04

1.1

—

Pain, not elsewhere classified

16.01

5.40

1.0

—

Abnormalities of breathing

5.38

5.28

1.0

1.1

—

Episodal and paroxysmal disorders

4.75

5.27

1.1

—

Other symptoms and signs involving cognitive functions and awareness

11.39

5.18

1.2

1.0

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

4.36

4.38

1.1

1.0

—

Persons encountering health services for specific procedures and health care

3.40

3.83

1.1

—

Sleep apnoea

4.31

3.80

1.1

—

Malaise and fatigue

9.18

3.67

1.0

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4.83

3.51

1.1

—

First line medication for Crohn's disease

3.42

3.50

1.1

—

Asthma, unspecified (mode)

8.42

3.46

1.1

1.2

—

Asthma, unspecified (mode), excluding more controls

8.34

3.44

1.1

1.2

—

Sleep apnoea, including avohilmo

3.42

3.38

1.1

—

ILD medications

3.28

3.31

1.1

—

Spondylopathies

4.33

3.27

1.0

1.1

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

3.24

3.26

1.2

1.0

—

Rotator cuff syndrome

5.16

3.23

1.2

1.1

—

Autoimmune diseases

3.04

3.13

1.0

1.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

3.28

3.12

1.1

—

Asthma (mode)

5.25

3.08

1.1

1.2

—

Complications of surgical and medical care, not elsewhere classified

3.10

3.04

1.1

—

Autoimmune diseases related-to ILD

3.34

2.94

1.0

1.1

—

Inflammatory bowel disease treatment related agents

2.99

2.93

1.0

1.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

7.09

2.92

1.0

—

Abnormal findings on diagnostic imaging of lung

5.52

2.89

1.1

—

Open wound of wrist and hand

3.95

2.78

1.0

—

Diagnoses used for exclusion with ILD

8.34

2.75

1.0

—

Dorsopathies

3.20

2.70

1.0

1.1

—

Symptoms and signs involving the digestive system and abdomen

3.34

2.70

1.0

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.99

2.55

1.1

1.0

—

Other diseases of anus and rectum

7.12

2.54

1.0

1.1

—

Asthma

4.58

2.53

1.1

1.2

—

Asthma, excluding more controls

4.56

2.52

1.1

1.2

—

COPD differential diagnosis

4.45

2.46

1.1

1.2

—

ILD differential diagnosis

4.45

2.46

1.1

1.2

—

Other pulmonary diagnosis

4.45

2.46

1.1

1.2

—

Excluding asthma or asthma-COPD overlap

4.45

2.46

1.1

1.2

—

Other and unspecified anaemias

5.12

2.41

1.5

1.1

—

Other anaemias

5.10

2.41

1.5

1.1

—

Chronic lower respiratory diseases

2.63

2.38

1.1

—

Shoulder lesions

3.59

2.37

1.2

1.1

—

Impingement syndrome of shoulder

6.25

2.37

1.2

1.0

—

Aplastic and other anaemias

4.99

2.36

1.5

1.1

—

Dorsalgia

3.07

2.33

1.0

1.1

—

Other dorsopathies, not elsewhere classified

3.01

2.28

1.0

1.1

—

COPD related to multimorbidity

6.03

2.26

1.2

1.0

—

Tonsillectomy and adenotomy

3.29

2.24

1.0

1.1

—

ILD medications: immunosuppressive drugs

3.45

2.22

1.0

1.1

—

Herpesviral [herpes simplex] infections, including avohilmo

5.56

2.21

1.2

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

3.07

2.21

1.1

—

3.07

2.21

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

2.72

2.18

1.0

1.2

—

Depression or dysthymia

4.25

2.18

1.1

—

Influenza and pneumonia

2.64

2.16

1.1

—

Diseases of pulp and periapical tissues, including avohilmo

2.84

2.12

1.1

1.0

—

Diseases of the respiratory system

5.01

2.10

1.0

1.2

—

Other headache syndromes

4.98

2.06

1.2

1.0

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.14

2.04

1.1

1.0

—

Other chronic obstructive pulmonary disease

5.11

2.03

1.2

1.1

—

Autoimmune diseases excluding thyroid diseases

2.60

2.03

1.0

1.2

—

Arthrosis

3.08

2.02

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

2.61

1.99

1.1

—

Insulin, intermediate and long-acting

3.38

1.97

1.1

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

0.00

1.96

0.0

1.1

—

Cerebrovascular diseases (FINNGEN)

5.01

1.95

1.0

1.3

—

Pure hypercholesterolaemia

3.17

1.94

1.1

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.66

1.92

1.0

—

Migraine

3.89

1.92

1.0

1.1

—

Chronic apical periodontitis

2.49

1.90

1.1

—

Pain (limb, back, neck, head abdominally)

4.29

1.90

1.0

1.1

—

Used for control exclusion in common control thyroid runs

2.52

1.89

1.0

1.2

—

Oral corticosteroids

2.58

1.88

1.0

1.2

—

COPD

4.51

1.87

1.2

1.1

—

Disorders of lipoprotein metabolism and other lipidaemias

3.04

1.85

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

3.17

1.85

1.1

—

Medical observation and evaluation for suspected diseases and conditions

5.11

1.84

1.0

—

Other disorders of urethra and urinary system

2.93

1.82

1.1

1.2

—

Spondylosis

3.61

1.81

1.0

1.2

—

Pneumonias (Asthma/COPD co-morbidities)

2.48

1.80

1.1

—

Other/unspecified dorsalgia

4.11

1.80

1.2

1.1

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2.48

1.80

1.2

1.1

—

Chronic diseases of tonsils and adenoids

2.70

1.79

1.0

1.1

—

COPD, hospital admissions

4.21

1.79

1.2

1.1

—

All pneumoniae

2.46

1.78

1.1

—

COPD, early/later onset

4.20

1.78

1.2

1.1

—

Dizziness and giddiness

2.83

1.78

1.0

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

3.40

1.77

1.0

1.1

—

Complications of procedures, not elsewhere classified

2.59

1.77

1.1

—

Insulin medication

3.06

1.76

1.1

—

Implicit Sepsis

2.80

1.75

1.3

1.0

—

Abdominal and pelvic pain

2.79

1.75

1.0

1.1

—

Asthma (only as main-diagnosis)

3.73

1.75

1.2

—

Injuries to the wrist and hand

2.43

1.75

1.1

—

Appendectomy

2.72

1.75

1.1

—

Diabetes medication

2.47

1.75

1.1

—

Visual disturbances

3.33

1.74

1.2

1.1

—

Dermatophytosis, including avohilmo

2.70

1.74

1.1

—

Asthma (only as main-diagnosis), excluding more controls

3.68

1.73

1.2

—

Sleep disorders (combined)

2.50

1.73

1.0

1.1

—

Pneumonia, organism unspecified

2.64

1.71

1.1

1.0

—

Chronic periodontitis, complicated

3.25

1.70

1.2

1.1

—

Internal derangement of knee

3.81

1.70

1.0

1.1

—

Obesity related asthma

3.57

1.61

1.0

—

Chronic sinusitis

3.57

1.61

1.0

1.1

—

Diabetes, varying definitions

2.36

1.61

1.1

—

Cerebrovascular diseases

2.85

1.60

1.3

1.0

—

Diabetes mellitus

2.35

1.59

1.1

—

Anxiety (asthma-related co-morbidities)

2.80

1.59

1.0

1.1

—

Visual disturbances and blindness

3.00

1.58

1.2

1.1

—

Metabolic disorders

2.70

1.55

1.1

—

Certain infectious and parasitic diseases

2.65

1.53

1.1

—

Type 2 diabetes

2.41

1.52

1.1

—

Papulosquamous disorders

3.33

1.52

1.0

1.1

—

Bacterial infection, other or unspecified, including avohilmo

2.89

1.48

1.2

1.0

—

Parasetamol

2.72

1.45

1.0

1.1

—

Other bacterial diseases

2.38

1.44

1.1

1.0

—

Obesity due to excess calories

2.73

1.43

1.2

1.0

—

Meniscus derangement

2.84

1.42

1.0

1.1

—

Chronic periodontitis, including avohilmo

2.28

1.40

1.2

1.1

—

Periodontitis

2.27

1.40

1.2

1.1

—

Care involving use of rehabilitation procedures

2.70

1.40

1.2

1.1

—

Persons encountering health services in other circumstances, wide

2.34

1.40

1.0

—

Other (not insulin) diabetes medications

2.30

1.38

1.1

—

Type 2 diabetes, strict (exclude DM1)

2.28

1.37

1.1

—

Type 2 diabetes, definitions combined

2.28

1.37

1.1

—

Necrosis of pulp, including avohilmo

2.38

1.37

1.0

—

Type 2 diabetes, definitions combined, including avohilmo

2.26

1.36

1.1

—

Lower back pain or/and sciatica

2.14

1.34

1.0

1.1

—

Other bacterial diseases, including avohilmo

2.23

1.34

1.1

1.0

—

Implicit Sepsis, including avohilmo

2.48

1.32

1.3

1.0

—

Other chronic obstructive pulmonary disease, including avohilmo

2.93

1.32

1.2

1.1

—

Asthma (diagnoses ohter than nonallergic)

2.14

1.31

1.1

—

Complications of medical and surgical care

2.39

1.30

1.1

—

L04AX Other immunosuppressants

2.50

1.30

1.0

—

Gastrointestinal diseases

3.13

1.29

1.0

1.3

—

Organic, including symptomatic, mental disorders

2.93

1.29

1.2

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

2.36

1.26

1.1

—

Statin medication

2.60

1.26

1.0

—

Pain in limb

2.31

1.26

1.1

1.0

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

2.45

1.24

1.0

1.2

—

Other diseases of upper respiratory tract

2.17

1.22

1.0

1.2

—

Mood disorders, excluding more controls

2.24

1.22

1.0

1.1

—

Noninfective enteritis and colitis

2.63

1.21

1.0

1.1

—

Asthma, hospital admissions , main diagnosis only

2.17

1.21

1.1

1.0

—

All chronic kidney diseases

2.39

1.21

1.3

1.0

—

Asthma-related infections

2.34

1.20

1.0

—

Asthma, hospital admission 2, infections

2.34

1.20

1.0

—

Bacterial infection, other or unspecified

2.64

1.19

1.2

1.0

—

Substance abuse, excluding more controls

2.61

1.18

1.0

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2.13

1.17

1.3

1.0

—

Polyarthropathies

2.50

1.16

1.0

1.1

—

Low back pain

2.49

1.16

1.0

1.1

—

Pain in throat and chest

2.44

1.14

1.1

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

2.47

1.13

1.2

1.1

—

Other neurological diseases

2.36

1.13

1.0

1.1

—

Disorders of synovium and tendon

2.49

1.13

1.2

1.1

—

Obesity

2.35

1.12

1.1

—

Obesity and other hyperalimentation

2.35

1.12

1.1

—

Finngen Rheumatological endpoints

2.03

1.08

1.1

—

All anxiety disorders

2.17

1.06

1.0

—

Other nutritional deficiencies

2.13

1.05

1.1

—

Depression

2.00

1.05

1.0

1.1

—

Certain infectious and parasitic diseases, including avohilmo

2.50

1.05

1.0

1.1

—

GASTRO-related operations

2.19

1.05

1.0

1.1

—

Any gastric operation

2.19

1.05

1.0

1.1

—

Acute appendicitis

2.09

1.04

1.0

1.1

—

Anxiety disorders, excluding more controls

2.13

1.04

1.0

1.1

—

Periapical abscess

2.27

1.03

1.0

—

Artrosis, including avohilmo

2.13

1.03

1.0

1.1

—

Lumbar disc prolapse

2.31

1.02

1.0

1.1

—

Dental pulpitis, including avohilmo

1.92

1.01

1.2

1.0

—

Cystitis

2.08

1.01

1.0

1.2

—

Appendicitis, broad definition

2.02

1.00

1.0

1.1

—

Other antidepressants

1.91

1.00

1.0

1.1

—

Diseases of appendix

2.02

1.00

1.0

1.1

—

1.90

1.00

1.0

1.2

—

Benign neoplasm of colon, rectum, anus and anal canal

2.22

0.99

1.0

1.1

—

Injuries to the ankle and foot

1.99

0.98

1.1

1.0

—

Mood [affective] disorders

1.86

0.98

1.0

1.1

—

Mood disorders

1.86

0.98

1.0

1.1

—

Gonarthrosis,primary

2.01

0.97

1.0

1.1

—

Hypertension, essential

2.42

0.97

1.0

1.1

—

Tramadol

2.00

0.97

1.0

1.1

—

Bleeding

1.96

0.96

1.0

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

1.80

0.95

1.0

1.1

—

COPD/asthma related infections

2.11

0.94

1.0

1.1

—

COPD/asthma/ILD related infections

2.11

0.94

1.0

1.1

—

Other and unspecified dermatitis

2.22

0.93

1.2

1.0

—

Second line medication for Crohn's disease

2.22

0.93

1.0

1.1

—

Erysipelas, including avohilmo

2.22

0.93

1.2

1.0

—

Acute appendicitis, no complications

2.21

0.93

1.0

—

Type 2 diabetes, wide definition

2.22

0.93

1.0

1.1

—

Biguanides

2.01

0.92

1.1

—

Gonarthrosis [arthrosis of knee](FG)

2.16

0.90

1.0

1.1

—

Endocrine, nutritional and metabolic diseases

2.16

0.90

1.0

1.1

—

Other intervertebral disc disorders

2.10

0.89

1.0

1.1

—

Any mental disorder

1.91

0.88

1.0

1.1

—

Neurotic, stress-related and somatoform disorders

1.90

0.88

1.0

1.1

—

Anxiety disorders

1.89

0.88

1.0

1.1

—

Dermatitis and eczema

1.85

0.88

1.1

—

Dermatitis

2.02

0.87

1.2

1.1

—

Soft tissue disorders

1.86

0.86

1.1

1.0

—

Disorders of gallbladder, biliary tract and pancreas

1.78

0.83

1.1

—

Antihypertensive medication - note that there are other indications

1.96

0.82

1.0

1.1

—

Mycoses, including avohilmo

1.74

0.82

1.1

—

Malignant neoplasm of skin

0.00

0.81

0.0

1.1

—

Heart failure,strict

0.00

0.81

0.0

1.1

—

All-cause Heart Failure

0.00

0.80

0.0

1.1

—

Heart failure, strict

0.00

0.80

0.0

1.1

—

Varicose veins

0.00

0.80

0.0

1.1

—

Malignant neoplasm of skin, including Hilmo

0.00

0.79

0.0

1.1

—

Gonarthrosis

2.35

0.79

1.0

1.2

—

Cardiac arrhythmias

2.29

0.78

1.0

1.1

—

Any reimbursement code in KELA

2.28

0.78

1.0

—

Other diseases of urinary system

1.74

0.77

1.1

—

Hypertensive diseases (excluding secondary)

2.24

0.77

1.0

1.2

—

Missing teeth due to accident, extraction or parodontitis

2.13

0.75

1.0

1.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1.89

0.75

1.0

1.1

—

Stroke, including SAH

2.11

0.75

1.2

1.1

—

Other diseases of intestines

1.67

0.75

1.0

1.1

—

Artificial joint operation, meniscal resection

1.86

0.74

1.0

1.1

—

Mental and behavioural disorders due to alcohol

2.07

0.74

1.0

1.1

—

Other soft tissue disorders, not elsewhere classified

1.81

0.73

1.1

1.0

—

Intestinal infectious diseases, including avohilmo, including avohilmo

1.62

0.72

1.0

1.1

—

Provisional assignment of new diseases of uncertain etiology

1.98

0.72

1.2

1.0

—

Codes for special purposes

1.98

0.72

1.2

1.0

—

Hypertensive diseases

2.01

0.72

1.0

1.1

—

Hypertension

2.01

0.72

1.0

1.1

—

Alcohol use disorder, Swedish definition

1.97

0.72

1.0

1.1

—

Infections of the skin and subcutaneous tissue

1.97

0.71

1.2

1.0

—

Psychiatric diseases

1.75

0.71

1.0

1.1

—

Diseases of arteries, arterioles and capillaries

1.93

0.70

1.2

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

1.91

0.70

1.0

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

1.69

0.68

1.1

1.0

—

1.86

0.68

1.0

1.1

—

Substance abuse

1.86

0.68

1.0

1.1

—

1.81

0.66

1.0

1.1

—

Benign neoplasms

1.74

0.65

1.0

1.1

—

Mental and behavioural disorders due to psychoactive substance use

1.76

0.65

1.0

1.1

—

malignant neoplasm of male genital organs, including Hilmo

0.00

0.63

0.0

1.1

—

Benzodiazepine use

1.64

0.62

1.1

—

Cholecystectomy

1.70

0.62

1.2

1.1

—

Glaucoma

0.00

0.61

0.0

1.1

—

Basal cell carcinoma

0.00

0.60

0.0

1.1

—

Keratitis

0.00

0.60

0.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

0.00

0.60

0.0

1.1

—

Basal cell carcinoma, including Hilmo

0.00

0.60

0.0

1.1

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

0.00

0.60

0.0

1.1

—

Nerve, nerve root and plexus disorders

1.55

0.60

1.1

—

Symptoms and signs involving the urinary system

1.74

0.58

1.2

1.0

—

Asthma, including avohilmo

1.55

0.56

1.1

—

Diabetes, insulin treatment (Kela reimbursement)

1.60

0.50

1.0

1.1

—

Other joint disorders

1.52

0.49

1.0

1.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1.51

0.48

1.3

1.1

—

Inguinal hernia

1.66

0.44

1.2

1.1

—

Bronchitis

1.45

0.43

1.0

1.1

—

Disorders of lens

1.63

0.43

1.0

1.2

—

Persons encountering health services in circumstances related to reproduction

1.60

0.43

1.0

—

Cardiovascular diseases (excluding rheumatic etc)

1.59

0.43

1.0

1.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

0.00

0.42

0.0

1.2

—

malignant neoplasm of male genital organs

0.00

0.42

0.0

1.1

—

Heart failure and coronary heart disease

0.00

0.42

0.0

1.2

—

Malignant neoplasm of prostate

0.00

0.42

0.0

1.1

—

Malignant neoplasm of prostate, including Hilmo

0.00

0.41

0.0

1.1

—

Glucosamine medication

0.00

0.41

0.0

1.1

—

Oxycodone

0.00

0.41

0.0

1.1

—

Other disorders of veins

0.00

0.41

0.0

1.1

—

Embedded and impacted teeth

0.00

0.40

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

0.00

0.40

0.0

1.1

—

Fracture at wrist and hand level

0.00

0.40

0.0

1.1

—

Atopic dermatitis

1.42

0.39

1.0

1.1

—

Disorders of choroid and retina

1.40

0.38

1.2

1.0

—

Neoplasms

1.50

0.37

1.0

—

Diseases of the eye and adnexa

1.43

0.36

1.0

1.1

—

Asthma/COPD (KELA code 203)

1.43

0.36

1.2

1.1

—

Dyspnoea

1.35

0.34

1.0

1.1

—

Acute upper respiratory infections

1.35

0.32

1.0

1.1

—

Caries of enamel

1.35

0.31

1.1

—

Opioids

1.29

0.31

1.0

1.1

—

Falls/tendency to fall

1.34

0.29

1.0

1.1

—

Cardiovascular diseases

1.40

0.24

1.0

1.1

—

External causes of morbidity and mortality

1.32

0.24

1.0

1.1

—

Injuries to the elbow and forearm

1.30

0.23

1.2

1.0

—

Cholelithiasis

1.26

0.23

1.2

1.1

—

Antenatal screening

0.00

0.22

0.0

1.0

—

Supervision of normal pregnancy

0.00

0.22

0.0

1.0

—

Cholelithiasis, broad definition with cholecystitis

1.23

0.22

1.2

1.1

—

Heart failure and bmi 25plus

0.00

0.22

0.0

1.1

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.22

0.0

1.0

—

Malignant neoplasm of breast, HER-positive

0.00

0.22

0.0

1.0

—

Non-ischemic cardiomyopathy

0.00

0.21

0.0

1.1

—

Hyperlipidaemia, other/unspecified

0.00

0.21

0.0

1.1

—

Benign thyroid growths and nodules

0.00

0.21

0.0

1.1

—

Primary open-angle glaucoma

0.00

0.21

0.0

1.1

—

Colorectal adenocarcinoma

0.00

0.21

0.0

1.0

—

Postpartum haemorrhage due to retained placenta

0.00

0.21

0.0

1.0

—

Viral warts, including avohilmo

0.00

0.21

0.0

1.0

—

Benign lipomatous neoplasm

0.00

0.21

0.0

1.1

—

Disturbances of skin sensation

0.00

0.21

0.0

1.1

—

Intestinal stricture

0.00

0.21

0.0

1.1

—

Diseases of salivary glands

0.00

0.21

0.0

1.1

—

Diaphragmatic hernia

0.00

0.21

0.0

1.1

—

Disorders of refraction and accommodation

0.00

0.21

0.0

1.1

—

Conjunctivitis (acute, non atopic)

0.00

0.21

0.0

1.1

—

Abnormal serum enzyme levels

0.00

0.21

0.0

1.1

—

Colorectal cancer

0.00

0.21

0.0

1.0

—

Actinic keratosis

0.00

0.21

0.0

1.1

—

Skin changes due to chronic exposure to nonionizing radiation

0.00

0.21

0.0

1.1

—

Selective serotonin reuptake inhibitors

1.30

0.21

1.2

1.1

—

Glaucoma suspect

0.00

0.21

0.0

1.1

—

Cardiodefibrillation

0.00

0.21

0.0

1.0

—

Gingivitis and periodontal diseases

1.29

0.21

1.2

1.1

—

Redundant prepuce, phimosis and paraphimosis

0.00

0.21

0.0

1.0

—

Malignant neoplasm of breast, HER2-negative

0.00

0.21

0.0

1.0

—

Malignant neoplasm of breast

0.00

0.21

0.0

1.0

—

Colorectal cancer, including Hilmo

0.00

0.21

0.0

1.0

—

Chronic rhinitis, nasopharyngitis and pharyngitis

0.00

0.21

0.0

1.1

—

Hypothyroidism, other/unspecified

1.27

0.20

1.0

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.27

0.20

1.0

1.1

—

Atherosclerosis, excluding cerebral and coronary sclerosis

0.00

0.20

0.0

1.1

—

Diseases of external ear

0.00

0.20

0.0

1.1

—

0.00

0.20

0.0

1.1

—

Codeine

1.20

0.20

1.0

1.1

—

Non-selective monoamine reuptake inhibitors

0.00

0.20

0.0

1.1

—

Intestinal infectious diseases

1.20

0.20

1.2

1.1

—

Codeine or tramadol medication

1.15

0.18

1.0

1.1

—

Renal tubulo-interstitial diseases

1.14

0.10

1.4

1.0

—

Arthropathies

1.05

0.09

1.0

1.1

—

Other external causes of accidental injury

1.04

0.09

1.0

1.1

—

Accidents

1.04

0.09

1.0

1.1

—

Hernia

1.04

0.09

1.2

1.1

—

Other heart diseases, wide

1.13

0.09

1.0

1.1

—

Fall on same level

1.10

0.08

1.0

1.1

—

Injuries to the knee and lower leg

1.05

0.08

1.1

—

Preterm labour and delivery

0.00

0.0

1.1

—

Supervision of high-risk pregnancy

0.00

0.0

1.0

—

Otitis externa

0.00

0.0

1.1

—

Embedded teeth, including avohilmo

0.00

0.0

1.0

—

Fracture of femur

0.00

0.0

1.0

—

Open wound of lower leg

0.00

0.0

1.0

—

Other hammer toe(s) (acquired)

0.00

0.0

1.0

—

Superficial injury of ankle and foot

0.00

0.0

1.0

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.0

1.0

—

Medicines for HER+ breast cancer

0.00

0.0

1.1

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

0.00

0.0

1.1

—

Malignant melanoma, including Hilmo

0.00

0.0

1.0

—

Enthesopathies of lower limb, excluding foot

0.00

0.0

1.1

—

All kidney diseases

0.93

0.00

1.2

1.1

—

Ectopic pregnancy

0.00

0.0

1.2

—

Premature rupture of membranes

0.00

0.0

1.0

—

Adverse effects, not elsewhere classified

0.00

0.0

1.0

—

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon

0.00

-0.00

0.0

1.0

—

Cardiomyopathies, Primary/intrinsic

0.00

-0.00

0.0

1.0

—

Deforming dorsopathies

0.00

-0.00

0.0

1.1

—

Other congenital malformations, including avohilmo

0.00

-0.00

0.0

1.0

—

Calcific aortic valvular stenosis, operated

0.00

-0.00

0.0

1.0

—

Cardiomyopathy

0.00

-0.00

0.0

1.0

—

Hypertensive heart and/or renal disease

0.00

-0.00

0.0

1.0

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

-0.00

0.0

1.0

—

Malignant melanoma

0.00

-0.00

0.0

1.0

—

Tooth eruption problems

0.00

-0.00

0.0

1.0

—

Inflammatory disease of uterus

0.00

-0.00

0.0

1.0

—

Benign neoplasm of other and ill-defined parts of digestive system

0.00

-0.00

0.0

1.0

—

Status post-ami

0.00

-0.00

0.0

1.0

—

Injury of muscle and tendon at lower leg level

0.00

-0.00

0.0

1.0

—

Acute renal failure

0.00

-0.00

0.0

1.0

—

Hypertrophy of breast

0.00

-0.00

0.0

1.1

—

Other hearing loss

0.00

-0.00

0.0

1.1

—

Acute nasopharyngitis (common cold)

0.00

-0.00

0.0

1.0

—

Nontoxic multinodular goitre

0.00

-0.00

0.0

1.2

—

DVT of lower extremities

0.00

-0.00

0.0

1.0

—

Myopia

0.00

-0.00

0.0

1.0

—

Acute and transient psychotic disorders

0.00

-0.00

0.0

1.0

—

Sleep disorders

0.96

-0.00

1.0

1.1

—

Other abnormal uterine and vaginal bleeding

0.00

-0.00

0.0

1.2

—

Car occupant injured in other and unspecified transport accidents

0.00

-0.00

0.0

1.0

—

Behavioural syndromes associated with physiological disturbances and physical factors

0.94

-0.00

1.0

1.1

—

Injuries to the head

0.96

-0.00

1.0

1.1

—

Injury of eye and orbit

0.00

-0.00

0.0

1.0

—

L02BA Anti-estrogens

0.00

-0.00

0.0

1.2

—

L02BG Aromatase inhibitors

0.00

-0.00

0.0

1.1

—

Other obstructed labour

0.00

-0.00

0.0

1.2

—

Diseases of oesophagus, stomach and duodenum

1.01

-0.00

1.0

1.1

—

Poor fetal growth

0.00

-0.00

0.0

1.0

—

Disorders of the thyroid gland

0.98

-0.00

1.0

1.1

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

-0.00

0.0

1.0

—

Other disorders of the musculoskeletal system and connective tissue

0.00

-0.00

0.0

1.0

—

Diseases of the skin and subcutaneous tissue

0.93

-0.00

1.2

1.1

—

Nasal polyp

0.00

-0.00

0.0

1.1

—

Other disorders of breast

0.00

-0.00

0.0

1.2

—

malignant neoplasm of female genital organs, including Hilmo

0.00

-0.00

0.0

1.0

—

LSIL lesion of the cervix uteri, vagina or vulva

0.00

-0.00

0.0

1.0

—

Lichen planus, including avohilmo

0.00

-0.00

0.0

1.2

—

Other gastritis (incl. Duodenitis)

0.00

-0.00

0.0

1.1

—

Cardiomyopathy (excluding other)

0.00

-0.00

0.0

1.0

—

Seborrhoeic keratosis

0.00

-0.00

0.0

1.2

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

0.00

-0.00

0.0

1.0

—

Other or unspecified ileus, impaction or obstruction

0.00

-0.00

0.0

1.2

—

Valvular operations

0.00

-0.00

0.0

1.0

—

Benign neoplasm of breast

0.00

-0.00

0.0

1.2

—

Calcific aortic valvular stenosis, including rheumatic fever

0.00

-0.00

0.0

1.0

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

0.00

-0.00

0.0

1.0

—

Operations 2 for CAVS

0.00

-0.00

0.0

1.0

—

Nontoxic goitre/thyroid nodule

0.00

-0.00

0.0

1.2

—

Myocardial infarction, with ST-elevation

0.00

-0.00

0.0

1.0

—

Disorders of parathyroid gland

0.00

-0.00

0.0

1.2

—

Calcific aortic valvular stenosis, diagnosis (helper)

0.00

-0.00

0.0

1.0

—

0.00

-0.00

0.0

1.2

—

Blepharochalasis

0.00

-0.00

0.0

1.1

—

Primary open-angle glaucoma, strict

0.00

-0.00

0.0

1.1

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

0.00

-0.00

0.0

1.0

—

severe traumatic brain injury, does not include concussion

0.00

-0.00

0.0

1.0

—

Calcific aortic valvular stenosis

0.00

-0.00

0.0

1.0

—

Paralytic ileus and intestinal obstruction

0.00

-0.00

0.0

1.2

—

Other disorders of conjunctiva

0.00

-0.00

0.0

1.0

—

Follicular cysts of skin and subcutaneous tissue

0.00

-0.00

0.0

1.1

—

Corneal ulcer

0.00

-0.00

0.0

1.0

—

Phlebitis and thrombophlebitis (not including DVT)

0.00

-0.00

0.0

1.1

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

-0.00

0.0

1.1

—

Disorders of psychological development

0.00

-0.00

0.0

1.0

—

Hypertrophy of breast in women and men

0.00

-0.00

0.0

1.1

—

Hyperparathyroidism

0.00

-0.00

0.0

1.2

—

Schizophrenia

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of rectum, including Hilmo

0.00

-0.00

0.0

1.0

—

Stomatitis and related lesions

0.00

-0.00

0.0

1.0

—

Use of pramipexole

0.00

-0.00

0.0

1.1

—

LSIL lesion of the cervix uteri

0.00

-0.00

0.0

1.0

—

Endometriosis diagnosis and infertility diagnosis occurring together

0.00

-0.00

0.0

1.0

—

Hydrocele

0.00

-0.00

0.0

1.0

—

Other menopausal disorders

0.00

-0.00

0.0

1.2

—

Acute laryngitis and tracheitis

0.00

-0.00

0.0

1.0

—

Benign neoplasm of ovary

0.00

-0.00

0.0

1.2

—

Other and unspecified urticaria

0.00

-0.00

0.0

1.1

—

Fibroblastic disorders

0.00

-0.00

0.0

1.0

—

Congenital malformations of the circulatory system

0.00

-0.00

0.0

1.0

—

Postmenopausal atrophic vaginitis

0.00

-0.00

0.0

1.2

—

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

0.00

-0.00

0.0

1.0

—

Long labour

0.00

-0.00

0.0

1.1

—

Maternal care for known or suspected fetal abnormality and damage

0.00

-0.00

0.0

1.0

—

Postpartum haemorrhage due to anatomy

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin

0.00

-0.00

0.0

1.0

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

0.00

-0.00

0.0

1.0

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of colon, including Hilmo

0.00

-0.00

0.0

1.0

—

Malignant melanoma of skin, including Hilmo

0.00

-0.00

0.0

1.0

—

Candidiasis, including avohilmo

0.00

-0.00

0.0

1.1

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Neutrophils [#/volume] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS